View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/HRSA | RIN: 0906-AB04 | Publication ID: Spring 2014 |
| Title: 340B Drug Pricing Program Regulations | |
| Abstract: This proposed rule would establish comprehensive 340B Drug Pricing Program requirements for participating covered entities and manufacturers. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: Undetermined | Unfunded Mandates: No |
| CFR Citation: None (To search for a specific CFR, visit the Code of Federal Regulations.) | |
| Legal Authority: 42 USC 256b 42 USC 216 | |
|
Legal Deadline:
None |
||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Small Entities Affected: No | Federalism: No |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Krista Pedley Director, Office of Pharmacy Affairs Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau, 5600 Fishers Lane, Rockville, MD 20857 Phone:301 594-4353 Email: krista.pedley@hrsa.hhs.gov |
|
An official website of the United States government



